Pediatric Healthcare Market Size, Share Report, Analysis, Trends, Growth 2032

Table Of Content

Methodology

Free Analysis

Pediatrics is the branch of medicine that deals with the health, growth, and development of adolescents, infants, and children along with their chances of achieving the full potential as adults. It emphasizes on children’s well-being, right from conception to adolescence. The medical branch of pediatrics is categorized into various different sub-branches—pediatric immunology, pediatric dermatology, pediatric cardiology, pediatric oncology, and pediatric critical care. Pediatric healthcare mainly includes nutrition, vaccines, and drugs, which help children to grow up healthy. Pediatric care involves a broad range of health and development services, ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. Pediatric healthcare is a discipline concerning the social, biological, and environmental influences on a child and the impact of various diseases and dysfunctions on his/her overall development.

The global pediatric healthcare market is likely to grow notably, due to the exponential increase in the demand for chronic disease treatment, changes witnessed in childcare trends, increase in the obese population base due to sedentary lifestyle, rise in the number of hospitals and clinics, improvements in healthcare infrastructure in developing economies, high acceptance rate of pediatric healthcare, escalation in starvation among pediatric population, advancements in medical technology, and supportive government initiatives. However, the high treatment cost may limit the pediatric healthcare market growth globally.

The pediatric healthcare market is fragmented on the basis of type, indication, and treatment. Based on type, the market is segmented into chronic illness and acute illness. The chronic illness segment held the largest market share in 2018, due to the increasing prevalence of chronic disease and growing treatment demand for diseases. By indication, the market is categorized into cardiac disorders, asthma and allergies, genetic disorders, metabolic disorders, and others. Allergies and metabolic disorders together held the largest market shares in 2018, owing to the increasing obese population. The treatment segment includes immunotherapy, medication, surgeries, and others.

North America dominated the global pediatric healthcare market with a major revenue share in 2018, due to the launch of new drugs by pharmaceutical companies for pediatric patients, increasing adoption of modern medical technology, and the regional presence of the key market players. North America is estimated to remain at the top position over the forecast period as well. Europe held the second spot in the global pediatric healthcare market in 2018, due to the increasing demand for chronic disease treatment and growing enterprises of medical hospitals and clinics. The Asia Pacific pediatric healthcare market will register the highest CAGR over the forecast time period, owing to the various improvement in the healthcare infrastructure and the increasing children population suffering from diseases and disorders.

Some key players operating in the global pediatric healthcare market are GlaxoSmithKline, AstraZeneca, Pfizer, Merck, Boehringer Ingelheim, Pediapharm, Sanofi, Gilead Sciences, Eisai, and Mylan.